Trivalent influenza vaccine in patients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components.

@article{Beyer1987TrivalentIV,
  title={Trivalent influenza vaccine in patients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components.},
  author={Walter E. P Beyer and D. J. Versluis and Peter Kramer and P. P. N. M. Diderich and Willem W Weimar and Nathalie Masurel},
  journal={Vaccine},
  year={1987},
  volume={5 1},
  pages={
          43-8
        }
}
One hundred and one patients on haemodialysis, 21 patients on peritoneal dialysis and 30 healthy controls received a trivalent split vaccine containing 15 micrograms haemagglutinin of a recent influenza A-H3N2, influenza A-H1N1 and influenza B strain, respectively. Antibody production after four weeks was determined by the haemagglutination-inhibition test and expressed as response rate, protection rate and overall mean fold increase. The patients on haemodialysis revealed a diminished… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Immunogenicity and reactogenicity of two doses of a trivalent influenza split vaccine. An open randomized study in healthy, unprotected, adult volunteers

  • W.E.P. Beyer, M.W.E. Teunissen, R.J.A. Diepersloot, N. Masurel
  • J. Drug Res.,
  • 1986

Antibody response to immunization with influenza A/USSR/77 (HIN1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N 1) virus

  • N. Masurel, P. Ophof, P. De Jong
  • J. Hyg
  • 1981

Similar Papers

Loading similar papers…